Thematic Certificate · AMC
MGF
BioSciences
Biotechnology and healthcare, at the frontier of tomorrow's medicine.
Investing in medical innovation.
Certificate price
Biotechnology is no longer a scientific bet. It already accounts for 30% of drug sales worldwide.
MGF BIOSCIENCES
Medicine moves into the genomic era
Sequencing a full genome, which cost 3 billion dollars in 2000, is heading towards 100 dollars. The 2020 Nobel Prize in Chemistry recognised CRISPR-Cas9, the genetic scissors opening a new generation of therapies. Global health spending is expected to reach 15 trillion dollars by 2030, driven by an ageing population. The American population aged over 65 will double by 2060.
The portfolio covers strategic segments such as medical devices, genetics, rare diseases, diagnostics, oncology and proteins and enzymes, favouring companies with strong potential, often at the frontier of applied research. It thus captures the potential of major medical innovations, carried by scientific advances, demographic change and rising healthcare needs.
Portfolio sector breakdown
Portfolio selection
- Moderna Inc 8.0%
- Regeneron Pharmaceuticals Inc 6.4%
- Amgen Inc 5.5%
- Quest Diagnostics Inc 4.5%
- Illumina Inc 4.3%
4 out of 5 drugs in development come from biotech
Large pharmaceutical groups depend on them. They buy the small companies that invent them.
MGF BioSciences
Thematic certificate
Listed on SIX and hedged into Swiss francs, MGF BioSciences offers diversified exposure to innovative biotechnology companies. It spans strategic segments such as medical devices, genetics, rare diseases, diagnostics, oncology, and proteins and enzymes, favouring high-potential companies often at the frontier of applied research. It thereby captures the promise of major medical innovations, driven by scientific advances, demographic change and rising healthcare needs.
3 reasons
to invest
An electrification supercycle is underway. AI, data centres and decarbonisation are creating unprecedented structural demand for electricity production companies.
Our other thematic certificates
Artificial Intelligence
Exposure to the world's AI leaders, semiconductors, cloud, large language models and the infrastructure of the digital future.
Discover → AMC · CH0566790223Natural Resources
Access to strategic natural resources, critical metals, energy and raw materials essential to the global energy transition.
Discover → AMC · CH0551342501Global Infrastructure
Investment in major global infrastructure, transport, energy, communication and long-term strategic projects.
Discover →Would you like to invest in our MGF BioSciences, AMC certificate | MG Finance certificate?
To invest in one of our thematic certificates, you do not need a securities account with MG Finance or with our partner banks. You can simply place an instruction with your own bank, quoting the ISIN, the valor number or the symbol.
Contact us →MG Finance SA · Av. du Général Guisan 46a, 1009 Pully · +41 21 614 75 75 · research@mgfinance.ch